Podcast
Podcast: This Week in Managed Care—The Top Managed Care News From the First Half of 2019
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This week, we recap the top managed care news from the first half of 2019, including outcomes from some of the biggest diabetes trials, research into the annual Medicare wellness visit, and an experimental treatment in Parkinson disease.
Listen above or through one of these podcast services:
Medicare Annual Wellness Visit Association With Healthcare Quality and Costs
Cardiovascular Prevention Guidelines Call for Less Aspirin, More SGLT2s, GLP-1s for Type 2 Diabetes
New Treatment May Have the Potential to Slow, Stop, or Reverse Parkinson Disease
Oral Semaglutide Meets CV Safety Mark, Reduces Events in High-Risk T2D Patients
Novo Nordisk Seeks Oral Semaglutide Approval, CV Indications on New Drug and Injectable
CREDENCE: Canagliflozin Cuts Risk of Renal Failure, Death 30% in Patients With Type 2 Diabetes, CKD
Read more about the stories in this podcast:
